4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-049242
President, R&D sold 25,000 shares at $30.00 ($750,000)
- President, R&D acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bergstrom Donald A President, R&D | 2022-09-08 | Option exercise | +25,000 | $4.12 | $103,000 | 114,659 | D |
| Bergstrom Donald A President, R&D | 2022-09-08 | Sale | −25,000 | $30.00 | $750,000 | 89,659 | D |
| Derivatives | |||||||
| Bergstrom Donald A President, R&D | 2022-09-08 | Option exercise · Stock Option (Right to Buy) | −25,000 | 109,456 | D | ||
| Open-market sales · 25,000 sh · avg $30.00 · $750,000 | |||||||
Loading xslF345X03/doc4.xml…